Neurological diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis, pose a significant global health challenge due to their complex pathogenesis and widespread ...

Murray, T. J. (2004). Multiple sclerosis: the history of a disease. Demos Medical Publishing. National Institute of Allergy and Infectious Diseases. National Institutes of Health Website.

Researchers from several institutions in Brazil developed an enhanced protocol for extracting and analyzing proteins from human skin, combining chemical and mechanical lysis, SP3 sample preparation, ...

In recent years, the FDA has approved three complement inhibitors for gMG -- eculizumab (Soliris), ravulizumab (Ultomiris), ...

Panelists discuss the shift toward patient-centered outcomes in idiopathic pulmonary fibrosis and progressive pulmonary fibrosis treatment, emphasizing quality of life and symptom relief alongside ...

Panelists discuss that improving outcomes for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) requires multifaceted efforts including developing ...

Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug ...

Dysphonia is a common condition of abnormal voice production, often caused by problems with the voice box or vocal cords.

The increasing demand for donor hearts presents both a critical challenge and a significant opportunity for innovation in ...

Since the emergence of the Zika virus epidemic in 2014 and the associated novel sequalae that emerged, much has been learned about the effects of antenatal exposure to Zika virus. Zika virus in ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.